期刊文献+

子宫颈癌患者D-二聚体(DD)在血浆中的水平 被引量:3

Plasma Level of D-dimer(DD) in Patients with Cervical Cancer
在线阅读 下载PDF
导出
摘要 目的 :探讨子宫颈癌患者治疗前D二聚体 (DD)在血浆中的水平与手术 -病理分期、肿瘤大小、组织学分型和淋巴节状态的相关性。方法 :测定了 4 8例子宫颈癌患者术前血浆中D -二聚体 (DD) ,患者均进行了子宫完全切除术和骨盆淋巴结切除术。患者术后病理分期 ,Ⅰb 2 1例 ,Ⅱa 12例 ,Ⅱb 15例 ;肿瘤大小 :2 6例患者≤ 4cm ,2 2例 >4cm ;组织学分型 :鳞癌 39例 ,腺癌 9例 ;13例骨盆淋巴结阳性。结果 :术后病理分期Ⅱb患者的血浆DD水平明显高于正常对照组 ,但Ⅰb ,Ⅱa患者升高不明显。血浆DD水平与手术病理分期 (Ⅱb相对于Ⅰb、Ⅱa ,P <0 .0 0 1)和肿瘤大小(>4cm相对于≤ 4cm ,P <0 .0 0 5 )相关。结论 :Ⅱb期子宫颈癌患者DD在血浆中的水平明显升高。 Objective: To explore the relationship between the pretreatment plasma level of D-dimer with tumor stage, size, histological type, and lymph node status in patients with cervical cancer. Methods: The preoperative plasma level of D-dimer(DD) was measured in 48 patients with cervical cancer undergoing radical hysterectomy with pelvic lymphadenectomy. The surgical-pathological stage of disease was Ⅰb in 21 patients, Ⅱa in 12 patients,and Ⅱb in 15 patients. The tumor size was≤4㎝ in 26 patients and >4㎝ in 22 patients. The histological type was squamous cell carcinoma in 39 patients and adenocarcinoma in 9 patients. Positive pelvic lymph nodes were found in 13 patients. Results: To compared with controls, DD level was significantly raised in patients with surgical-pathological stage Ⅱb disease but not in patients with stage Ⅰb or Ⅱa disease. The values of DD were related to surgical-pathological stage (stageⅡb vs stageⅠb-Ⅱa:P<0.001) and tumor size (>4cm vs ≤4cm,P<0.005). Conclusions: Significantly increased DD level occur in patients with stage Ⅱb. Measurement of preoperative DD level would be useful in the preoperative diagnosis of tumor stage.
出处 《青海医药杂志》 2004年第12期7-9,共3页 Qinghai Medical Journal
关键词 患者 DD 血浆 子宫颈癌 肿瘤大小 D-二聚体 术后病理分期 水平 结论 目的 D-dimer Cervical cancer Tumor stage
  • 相关文献

参考文献11

  • 1[1]Rickles, F.R, Edwards,R.L. Activation of blood coagulation in cancer:Trousseau's syndrome revisited. Blood,1983,62:14~31.
  • 2[2]Patterson, W.P, Scott Ringenberg, Q. The pathophysiology of thrombosis in cancer, Semin. Oncol,1990,17:140~146.
  • 3[3]Zacharski, L.R, Costantini, V, Wojtukiewicz, M.Z,et al.Anticoagulants as cancer therapy, Semin.Oncol,1990,17:217~227.
  • 4[4]Von Tempelhoff GF, Dietrich M, Niemann F,et al.Blood coagulation and thrombosis in patients with ovarian malignancy, Thromb. Haemost,1997,77:456~461.
  • 5[5]Blackwell K, Haroon Z, Broadwater G,et al. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status, J. Chin. Oncol.2000,18:600~608.
  • 6[6]Olt,J.G. Greenberg C. Synam,I,et al.Preoperative assessment of fragment D-dimer as a predictor of postoperative venous thrombosis, Am. J. Obstet. Gynecol,1990,162:772~775.
  • 7[7]Bachmann, F, Kruithof I.Tissue plasminogen activator: Chemical and physiological aspects, Semin. Thromb. Hemost,1984,10:6~17.
  • 8[8]Gadducci A,Baicchi U, Del Bravo,et al.The assessment of the hemostasis system in patients with ovarian and cervical carcinoma, Cancer J,1991,4:183~187.
  • 9[9]Patterson, W P. Coagulation and cancer: An overview, Semin. Oncol,1990,17:137~139.
  • 10[10]Markus, G. The role of hemostasis and fibrinolysis in the metastatic spread of cancer, Semin. Thromb. Hemost,1984,10:61~70.

同被引文献35

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部